Next-generation biomaterial being developed to treat bleeding

PHOENIX ? Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery. The Nov. 16 cover article, ?An Injectable Shear-Thinning Biomaterial for Endovascular Embolization,? in the journal Science Translational Medicine reports on a universal shear-thinning [...]
Source: Mayo Clinic Arizona News - Category: Hospital Management Source Type: news